Thanks Macenroc
If I'm interpreting (guessing) that correctly, the ann on the 15th will be just the abstract info (summary data) and the follow up after ASCO will be the full detailed presentation.
Did you happen to listen in on the call? I was out.
I'm curious about one item in the slide presentation on slide 6, last point. Does it mean they already have this approval for continuation of the trial in Aust/USA or is submission still pending?
Cheers
K
Ann: Prima Newsletter , page-12
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.005(1.59%) |
Mkt cap ! $465.4M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 32.5¢ | 31.0¢ | $1.599M | 5.009M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 65758 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 6777 | 1 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |